ÂÜÀòÂÒÂ×

Yingmin Wang is an experienced professional with a strong background in medtech investments and business development. Currently serving as the Director of Medtech Investments at ClavystBio, Yingmin Wang focuses on investments, portfolio management, and partnerships in Digital Health, MedTech, Diagnostics, and BioTools. Additionally, Yingmin Wang holds board positions at Sunbird Bio, Allay Therapeutics, and One BioMed Pte Ltd. Formerly, in a role at Applied Materials, Yingmin Wang was involved in new business development and served as Chief of Staff for the South East Asia Regional Office. Yingmin Wang's prior experience includes leadership positions at the Singapore Economic Development Board and A*STAR, as well as a research role at the California Institute of Technology. Yingmin Wang holds a PhD in Bioengineering from Caltech and a BSc in Biomedical Engineering from Duke University.